Varicella, commonly known as chickenpox, is a highly contagious viral infection that causes an itchy, blister-like rash across the body. While the disease has become much less common thanks to widespread vaccination, understanding how to manage symptoms and knowing when medical care is necessary remains essential for families and healthcare providers. Treatment focuses on relieving discomfort, preventing complications, and protecting those at higher risk of severe illness.

Managing Chickenpox: A Path to Recovery and Comfort

When someone develops varicella, the primary goal of treatment is to help the body fight off the infection while managing symptoms and preventing complications. Since chickenpox is caused by the varicella-zoster virus (a member of the herpes virus family), the infection must run its course, typically lasting about 4 to 7 days.^[1] The approach to treatment varies significantly depending on the person’s age, overall health status, and whether they belong to groups at higher risk of developing serious problems from the infection.

Treatment decisions take into account several factors. For most healthy children, chickenpox resolves on its own with supportive care at home. However, certain groups require closer medical supervision and may need specific medications. These groups include infants under one year old, adolescents, adults, pregnant women, people with weakened immune systems, and individuals taking medications such as chemotherapy, immunosuppressive drugs, or long-term steroids.^[4] The severity of the rash and the presence of complications also guide treatment choices.

One of the most important aspects of managing chickenpox is recognizing when home care is sufficient and when professional medical attention becomes necessary. Understanding the available treatment options empowers patients and families to provide effective care while minimizing the risk of complications.

Standard Medical Treatment for Varicella

For most healthy children with chickenpox, standard treatment focuses on symptom relief rather than fighting the virus directly. The itchy rash, which is the hallmark of chickenpox, causes significant discomfort and requires careful management. Applying calamine lotion to the affected skin helps soothe itching without causing harm. This lotion contains zinc oxide, which has skin-calming properties.^[11] Parents and caregivers should avoid applying calamine near the eyes or on the face in sensitive areas.

Cool or lukewarm baths can provide substantial relief from itching. Adding colloidal oatmeal, baking soda, or commercially available oatmeal bath products to the water enhances the soothing effect. These baths should last no more than 20 minutes and can be repeated every 3 to 4 hours, especially during the first few days when itching is most intense.^[11] After bathing, the skin should be gently patted dry with a soft towel rather than rubbed, as rubbing can irritate the blisters and increase the risk of bacterial infection.

Managing fever is another component of standard care. Fever often accompanies chickenpox, appearing one to two days before the rash develops. Acetaminophen (commonly known as Tylenol) is recommended to reduce fever and ease discomfort. The medication should be given according to the instructions on the label, with appropriate dosing based on the child’s age and weight.^[11] Healthcare providers generally advise against using ibuprofen when possible, as it has been associated with life-threatening bacterial skin infections in children with chickenpox.

Preventing scratching is crucial because scratching the blisters can lead to bacterial skin infections, scarring, and spread of the virus to other parts of the body. Keeping fingernails short and clean reduces the damage that can occur from scratching. For young children and babies, soft mittens or gloves worn during sleep prevent unconscious scratching during the night.^[11] If scratching does occur and a blister breaks, washing hands thoroughly with soap and water for at least 20 seconds helps prevent the spread of bacteria.

For people at higher risk of complications, antiviral medications may be prescribed. The most commonly used antiviral is acyclovir, which works by interfering with the virus’s ability to multiply. When given within the first 24 hours after the rash appears, acyclovir can shorten the duration of the illness and reduce the severity of symptoms.^[10] The standard dose for older children and adults is 800 mg taken by mouth five times daily for 7 to 10 days. Other antiviral medications include valacyclovir (Valtrex) and famciclovir, which may be prescribed in certain situations.

Healthcare providers typically recommend antiviral treatment for specific groups of patients. These include otherwise healthy people older than 12 years of age, individuals with chronic skin or lung diseases, people receiving long-term salicylate therapy or steroid treatment, pregnant women, and those with weakened immune systems.^[11] For severely immunocompromised patients or those with visceral, central nervous system, or disseminated varicella infections, intravenous acyclovir at a dose of 10 mg per kilogram every 8 hours for 7 to 10 days is the standard treatment.^[14]

Special considerations exist for treating chickenpox blisters that appear inside the mouth. These sores can make eating and drinking painful, potentially leading to dehydration. Offering cold, soft, bland foods like smoothies or sugar-free popsicles helps soothe mouth sores while ensuring adequate fluid intake.^[11] Avoiding acidic, salty, or spicy foods prevents further irritation of the sensitive oral tissues.

In cases where bacterial infection of the skin develops as a complication of chickenpox, antibiotics may be necessary. Signs of bacterial infection include increased redness, warmth, swelling around the blisters, pus drainage from the lesions, and fever that persists or worsens.^[11] Prompt medical attention ensures that such complications are identified and treated before they become more serious.

Protective Measures for High-Risk Individuals

For people who have been exposed to chickenpox but are at high risk for severe disease, preventive treatment options exist. Varicella-zoster immune globulin (VariZIG) is a preparation of antibodies that can reduce the severity of infection if given within 10 days of exposure, ideally within 4 days.^[14] This treatment is particularly important for immunocompromised patients without evidence of immunity to varicella.

VariZIG is also recommended for newborn infants whose mothers develop chickenpox symptoms between 5 days before delivery and 2 days after delivery. The antibodies provide passive immunity, offering temporary protection during the period when the newborn is most vulnerable.^[14] Hospitalized premature infants born at 28 weeks of gestation or later whose mothers lack immunity to varicella may also receive VariZIG if exposed to the virus.

The chickenpox vaccine itself can be used as a form of post-exposure prevention. If given within 3 to 5 days after exposure to someone with chickenpox, the vaccine may prevent the disease entirely or result in a much milder form of the illness.^[1] This strategy is particularly useful for household contacts and other close contacts of infected individuals who have not previously had chickenpox or been vaccinated.

Vaccination: The Most Effective Prevention Strategy

While not technically treatment for active disease, vaccination represents the most important tool in preventing varicella altogether. The chickenpox vaccine has dramatically reduced the burden of disease since its introduction in 1995. Before the vaccine became available, nearly everyone developed chickenpox during childhood. Since widespread vaccination began in the late 1990s, chickenpox cases have declined by approximately 90 percent.^[13]

The current vaccination schedule recommends that children receive two doses of chickenpox vaccine: the first between 11 and 15 months of age, and the second between 15 and 23 months of age. For older children who have not yet been vaccinated, catch-up vaccination is recommended with two doses given at least three months apart for children 12 years and younger.^[6] Teenagers and adults who have never had chickenpox or been vaccinated should receive two doses four to eight weeks apart.

The vaccine is highly effective. Most people who receive both recommended doses will not get chickenpox at all. In the small percentage of vaccinated individuals who do develop breakthrough infections, the disease is typically much milder, with fewer than 50 skin lesions, shorter duration of illness, and little or no fever.^[5] The rash in these breakthrough cases may also look different, appearing more as red bumps without the characteristic fluid-filled blisters.

Emerging Approaches in Clinical Research

While the standard treatments for varicella have remained relatively stable over the past several decades, ongoing research continues to explore ways to improve outcomes, particularly for high-risk patients. Clinical trials and research studies examine various aspects of varicella treatment, from developing more effective antiviral medications to finding better ways to prevent the rare but serious complications of the disease.

One area of research focus involves improving antiviral therapy for patients with acyclovir-resistant strains of varicella-zoster virus. Although resistance is rare, it can occur in severely immunocompromised patients who have received prolonged antiviral treatment. In such cases, alternative antiviral agents may be needed. Foscarnet, an antiviral medication that works through a different mechanism than acyclovir, has been used in some cases of resistant varicella infections.^[14] Research continues to evaluate the effectiveness and safety of foscarnet and other alternative treatments in this challenging patient population.

Studies also examine the optimal timing and dosing of antiviral medications. While current guidelines recommend starting acyclovir within 24 hours of rash onset for maximum benefit, researchers investigate whether extending this window or adjusting doses might provide additional advantages for certain patient groups. Understanding how to best use existing medications helps clinicians provide more targeted and effective care.

Research into improved formulations of varicella-zoster immune globulin aims to make this preventive treatment more widely available and easier to administer. Studies evaluate the effectiveness of different dosing schedules and routes of administration, seeking to optimize protection for high-risk individuals exposed to the virus.

Another area of investigation involves developing better methods to diagnose varicella quickly and accurately. While most cases can be diagnosed based on the characteristic appearance of the rash, laboratory confirmation has become increasingly important as chickenpox becomes rarer due to vaccination. Polymerase chain reaction (PCR) testing, which detects the genetic material of the virus, is now the preferred method for laboratory confirmation.^[5] Research continues to develop faster, more accessible diagnostic tests that could be used in various healthcare settings.

Clinical trials also explore ways to improve the chickenpox vaccine itself. Studies examine whether different vaccine formulations, schedules, or booster strategies might provide even better protection or longer-lasting immunity. Researchers investigate combination vaccines that could protect against varicella along with other diseases, potentially reducing the number of injections children need to receive.

For patients who develop complications from varicella, such as pneumonia or encephalitis (inflammation of the brain), clinical research seeks to identify the most effective treatment approaches. Studies evaluate different combinations of antiviral medications, supportive therapies, and management strategies to improve outcomes for these seriously ill patients.

Some research focuses on preventing or treating postherpetic complications. Since the varicella-zoster virus remains dormant in nerve cells after chickenpox resolves, it can reactivate years or decades later to cause shingles. Understanding the relationship between initial varicella infection and later shingles development may lead to better strategies for preventing both conditions.

Most Common Treatment Methods

• Symptom Relief Measures
  • Calamine lotion containing zinc oxide to soothe itchy skin
  • Cool or lukewarm baths with colloidal oatmeal, baking soda, or oatmeal bath products
  • Keeping fingernails short and clean to prevent skin damage from scratching
  • Using soft mittens or gloves during sleep for young children
  • Sugar-free popsicles to soothe mouth sores and maintain hydration
• Fever Management
  • Acetaminophen (Tylenol) for fever reduction and pain relief
  • Avoiding aspirin in children due to risk of Reye syndrome
  • Avoiding ibuprofen when possible due to association with bacterial skin infections
• Antiviral Medications
  • Acyclovir (Zovirax, Sitavig) given orally at 800 mg five times daily for 7-10 days
  • Intravenous acyclovir at 10 mg/kg every 8 hours for severe cases
  • Valacyclovir (Valtrex) as an alternative oral antiviral medication
  • Famciclovir as another option for antiviral treatment
  • Foscarnet for acyclovir-resistant cases in immunocompromised patients
• Preventive Treatment
  • Varicella-zoster immune globulin (VariZIG) within 10 days of exposure for high-risk individuals
  • Post-exposure vaccination within 3-5 days of exposure to prevent or reduce severity
  • Two-dose vaccination series as the primary prevention strategy
• Complication Management
  • Antibiotics for bacterial skin infections
  • Specialized treatment for pneumonia or encephalitis complications
  • Supportive care and monitoring for high-risk patients